Support PenkeFirst Trust NYSE Arca Biotech ETF
Portfolio
Holdings
| Symbol | Name | Country | Sector | Industry | Most recent quarter | % of Total Shares | % of Total Assets | Shares | Book Value | Market Price Value | Fundamental Score | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ACAD.NASDAQ | ACADIA Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.542 | 3.842 | 2.5m | $8.8m | $47.4m |
| |||||||||||||
| AGIO.NASDAQ | Agios Pharm | USA | Healthcare | Biotechnology | 2024-09-30 | 3.158 | 3.113 | 1.7m | $49.1m | $59.3m |
| |||||||||||||
| ALKS.NASDAQ | Alkermes Plc | USA | Healthcare | Drug Manufacturers - Specialty & Generic | 2024-09-30 | 0.818 | 3.419 | 1.3m | $10.2m | $40.7m |
| |||||||||||||
| BEAM.NASDAQ | Beam Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.65 | 2.869 | 1.3m | $12.9m | $34.7m |
| |||||||||||||
| BNTX.NASDAQ | BioNTech SE | USA | Healthcare | Biotechnology | 2024-09-30 | 0.185 | 4.337 | 440.7k | $35.6m | $52.8m |
| |||||||||||||
| CORT.NASDAQ | Corcept Therapeutics Incorporated | USA | Healthcare | Biotechnology | 2024-09-30 | 0.804 | 3.844 | 842.3k | $4.7m | $56m |
| |||||||||||||
| CPRX.NASDAQ | Catalyst Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.588 | 3.582 | 1.8m | $9.9m | $42.8m |
| |||||||||||||
| DVAX.NASDAQ | Dynavax Technologies Corporation | USA | Healthcare | Drug Manufacturers - Specialty & Generic | 2024-09-30 | 2.121 | 2.941 | 2.7m | $12.2m | $35.9m |
| |||||||||||||
| EXEL.NASDAQ | Exelixis Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.511 | 4.413 | 1.4m | $11.3m | $47.9m |
| |||||||||||||
| FGEN.NASDAQ | FibroGen Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 2.466 | 0.451 | 2.4m | -$4.8m | $1.1m |
| |||||||||||||
| GMAB.NASDAQ | Genmab AS | USA | Healthcare | Biotechnology | 2024-09-30 | 0.256 | 3.032 | 1.6m | $11m | $31m |
| |||||||||||||
| GRFS.NASDAQ | Grifols SA ADR | USA | Healthcare | Drug Manufacturers - General | 2024-09-30 | 0.688 | 3.798 | 4.6m | $56.7m | $30.8m |
| |||||||||||||
| HALO.NASDAQ | Halozyme Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.741 | 3.687 | 943.6k | $3.2m | $53.1m |
| |||||||||||||
| INSM.NASDAQ | Insmed Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.914 | 3.147 | 1.3m | $3.6m | $105.7m |
| |||||||||||||
| IONS.NASDAQ | Ionis Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 0.938 | 3.794 | 1.3m | $5.6m | $43.1m |
| |||||||||||||
| PTCT.NASDAQ | PTC Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-09-30 | 1.845 | 3.513 | 1.4m | -$19.3m | $70.7m |
| |||||||||||||
| QGEN.NYSE | Qiagen NV | USA | Healthcare | Diagnostics & Research | 2024-09-30 | 0.449 | 3.472 | 1m | $16.1m | $44.9m |
| |||||||||||||
| RARE.NASDAQ | Ultragenyx | USA | Healthcare | Biotechnology | 2024-09-30 | 1.387 | 4.257 | 1.1m | $4.2m | $49.4m |
| |||||||||||||
| TECH.NASDAQ | Bio-Techne Corp | USA | Healthcare | Biotechnology | 2024-09-30 | 0.386 | 3.523 | 606.3k | $8m | $43.6m |
|
Trades
Adds
Report date: 2023-12-28
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| ALKS.NASDAQ | 73.00 | 0.0 | 1.8k | 22-29 | $30.76 | 39.8% |
Report date: 2022-11-30
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| AGIO.NASDAQ | 8.4k | 0.5 | 244k | 25-35 | $33.62 | 36.3% |
| ALKS.NASDAQ | 10.2k | 0.5 | 238.2k | 22-25 | $30.76 | 41.4% |
| BNTX.NASDAQ | 1.7k | 0.5 | 249.6k | 118-167 | $119.82 | 1.3% |
| EXEL.NASDAQ | 13.8k | 0.5 | 230.9k | 15-18 | $32.88 | 121.1% |
| FGEN.NASDAQ | 13.9k | 0.5 | 199.8k | 12-18 | $0.48 | -95.9% |
| GMAB.NASDAQ | 6.1k | 0.5 | 234.2k | 31-47 | $19.11 | -39.1% |
| GRFS.NASDAQ | 37.5k | 0.5 | 269.3k | 6-9 | $6.62 | 15.9% |
| RARE.NASDAQ | 5.9k | 0.5 | 239.1k | 33-50 | $43.42 | 30.2% |
| TECH.NASDAQ | 3.2k | 0.5 | 992.1k | 81-363 | $72.05 | -11.2% |
Reduces
Report date: 2023-12-28
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| ACAD.NASDAQ | -139.00 | 0.0 | -3.2k | 20-33 | $18.51 | -8.8% |
| AGIO.NASDAQ | -143.00 | 0.0 | -3.2k | 20-25 | $33.62 | 69.8% |
| BNTX.NASDAQ | -35.00 | 0.0 | -3.5k | 88-113 | $119.82 | 36.2% |
| EXEL.NASDAQ | -146.00 | 0.0 | -3.1k | 19-24 | $32.88 | 76.4% |
| GMAB.NASDAQ | -102.00 | 0.0 | -3.2k | 28-36 | $19.11 | -31.1% |
| GRFS.NASDAQ | -378.00 | 0.0 | -3.5k | 8-11 | $6.62 | -12.1% |
| RARE.NASDAQ | -92.00 | 0.0 | -3.5k | 32-50 | $43.42 | 37.8% |
Report date: 2023-08-31
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| ACAD.NASDAQ | -379.00 | 0.0 | -10.1k | 22-34 | $18.51 | -17.2% |
| AGIO.NASDAQ | -423.00 | 0.0 | -11.3k | 25-29 | $33.62 | 34.6% |
| ALKS.NASDAQ | -365.00 | 0.0 | -10.9k | 26-34 | $30.76 | 19.8% |
| BNTX.NASDAQ | -106.00 | 0.0 | -11.6k | 96-126 | $119.82 | 25.5% |
| EXEL.NASDAQ | -596.00 | 0.0 | -11.9k | 19-23 | $32.88 | 76.4% |
| GMAB.NASDAQ | -281.00 | 0.0 | -10.8k | 36-43 | $19.11 | -46.5% |
| GRFS.NASDAQ | -1.1k | 0.0 | -10.7k | 8-11 | $6.62 | -18.5% |
| RARE.NASDAQ | -271.00 | 0.0 | -11.8k | 34-55 | $43.42 | 26.5% |
Report date: 2023-08-30
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| ACAD.NASDAQ | -8.5k | -0.6 | -229k | 22-34 | $18.51 | -17.2% |
| AGIO.NASDAQ | -9.5k | -0.6 | -255.5k | 25-29 | $33.62 | 34.6% |
| ALKS.NASDAQ | -8.2k | -0.6 | -247.8k | 26-34 | $30.76 | 19.8% |
| BNTX.NASDAQ | -2.4k | -0.6 | -265.1k | 96-126 | $119.82 | 25.5% |
| EXEL.NASDAQ | -13.3k | -0.6 | -267.1k | 19-23 | $32.88 | 76.4% |
| GMAB.NASDAQ | -6.3k | -0.6 | -244.4k | 36-43 | $19.11 | -46.5% |
| GRFS.NASDAQ | -25.3k | -0.6 | -242.6k | 8-11 | $6.62 | -18.6% |
| RARE.NASDAQ | -6k | -0.6 | -266.9k | 34-55 | $43.42 | 26.5% |
Report date: 2023-06-29
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| ACAD.NASDAQ | -13.1k | -0.5 | -289.2k | 18-26 | $18.51 | 4.5% |
| AGIO.NASDAQ | -11.5k | -0.5 | -285.7k | 21-29 | $33.62 | 59.4% |
| ALKS.NASDAQ | -8.9k | -0.5 | -269.4k | 27-34 | $30.76 | 12.8% |
| BNTX.NASDAQ | -2.1k | -0.5 | -248.1k | 100-132 | $119.82 | 19.7% |
| EXEL.NASDAQ | -13.8k | -0.5 | -266.6k | 18-21 | $32.88 | 81.9% |
| FGEN.NASDAQ | -13k | -0.5 | -219.4k | 2-21 | $0.48 | -80.1% |
| GMAB.NASDAQ | -6.4k | -0.5 | -255.1k | 37-43 | $19.11 | -48.1% |
| GRFS.NASDAQ | -34.7k | -0.5 | -284.4k | 7-9 | $6.62 | -4.2% |
| RARE.NASDAQ | -6.1k | -0.5 | -284.9k | 37-55 | $43.42 | 16.7% |
Report date: 2022-09-29
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| ACAD.NASDAQ | -15.2k | -0.5 | -246.3k | 14-18 | $18.51 | 34.1% |
| AGIO.NASDAQ | -10.4k | -0.5 | -278.9k | 19-35 | $33.62 | 73.0% |
| ALKS.NASDAQ | -7.7k | -0.5 | -204.2k | 22-32 | $30.76 | 41.0% |
| BNTX.NASDAQ | -1.4k | -0.5 | -221.1k | 127-185 | $119.82 | -5.3% |
| FGEN.NASDAQ | -19.1k | -0.5 | -244.7k | 10-15 | $0.48 | -95.4% |
| GMAB.NASDAQ | -6.8k | -0.5 | -238.5k | 31-38 | $19.11 | -38.4% |
| GRFS.NASDAQ | -23k | -0.5 | -207.5k | 6-13 | $6.62 | 13.7% |
Comments
How you think about this?